You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 30, 2024

Alpharma Us Pharms Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for ALPHARMA US PHARMS, and what generic and branded alternatives to ALPHARMA US PHARMS drugs are available?

ALPHARMA US PHARMS has sixty-one approved drugs.

Summary for Alpharma Us Pharms

US Patents:	0
Tradenames:	43
Ingredients:	40
NDAs:	61

Drugs and US Patents for Alpharma Us Pharms

+ Get email alerts for changes to this table

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Alpharma Us Pharms	THEOPHYLLINE	theophylline	ELIXIR;ORAL	089223-001	May 27, 1988		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	HYDRAMINE	diphenhydramine hydrochloride	ELIXIR;ORAL	080763-002	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	NYSTATIN	nystatin	SUSPENSION;ORAL	062571-001	Oct 29, 1985		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	DEXAMETHASONE	dexamethasone	ELIXIR;ORAL	088997-001	Oct 10, 1986		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	FLUOCINOLONE ACETONIDE	fluocinolone acetonide	SOLUTION;TOPICAL	087159-001	Jun 16, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	BUTABARB	butabarbital sodium	ELIXIR;ORAL	085873-001	Approved Prior to Jan 1, 1982		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
Alpharma Us Pharms	TRIAMCINOLONE ACETONIDE	triamcinolone acetonide	OINTMENT;TOPICAL	089913-001	Dec 23, 1988		DISCN	No	No		⤷ Subscribe				⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for Alpharma Us Pharms

Subscribe to access the full database, or Subscribe
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-002	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-004	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
Alpharma Us Pharms	SERAX	oxazepam	CAPSULE;ORAL	015539-006	Approved Prior to Jan 1, 1982	4,620,974	⤷ Subscribe
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.